Literature DB >> 25809670

Evaluating the role of hnRNP-C and FMRP in the cAMP-induced APP metabolism.

D Rivera1, E Fedele, U M Marinari, M A Pronzato, R Ricciarelli.   

Abstract

Cyclic adenosine monophosphate (cAMP) modulates synaptic plasticity and memory and manipulation of the cAMP/protein kinase A/cAMP responsive element binding protein pathway significantly affects cognitive functions. Notably, cAMP can increase the expression of the amyloid precursor protein (APP), whose proteolytic processing gives rise to amyloid beta (Aβ) peptides. Despite playing a pathogenic role in Alzheimer's disease, physiological concentrations of Aβ are necessary for the cAMP-mediated regulation of long-term potentiation, supporting the existence of a novel cAMP/APP/Aβ cascade with a crucial role in memory formation. However, the molecular mechanisms by which cAMP stimulates APP expression and Aβ production remain unclear. Here, we investigated whether hnRNP-C and FMRP, two RNA-binding proteins largely involved in the expression of APP, are the cAMP effectors inducing the protein synthesis of APP. Using RNA immunoprecipitation and RNA-silencing approaches, we found that neither hnRNP-C nor FMRP is required for cAMP to stimulate APP and Aβ production.
© 2015 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  Alzheimer's disease; RNA-bindin protein; amyloid beta; amyloid precursor protein; forskolin

Mesh:

Substances:

Year:  2015        PMID: 25809670     DOI: 10.1002/biof.1207

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  3 in total

Review 1.  Fragile X and APP: a Decade in Review, a Vision for the Future.

Authors:  Cara J Westmark
Journal:  Mol Neurobiol       Date:  2018-09-17       Impact factor: 5.590

Review 2.  The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind.

Authors:  Roberta Ricciarelli; Ernesto Fedele
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 3.  Heterogeneous Nuclear Ribonucleoproteins: Implications in Neurological Diseases.

Authors:  Yi-Hua Low; Yasmine Asi; Sandrine C Foti; Tammaryn Lashley
Journal:  Mol Neurobiol       Date:  2020-09-30       Impact factor: 5.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.